244 related articles for article (PubMed ID: 16150935)
1. Dysfunctional T regulatory cells in multiple myeloma.
Prabhala RH; Neri P; Bae JE; Tassone P; Shammas MA; Allam CK; Daley JF; Chauhan D; Blanchard E; Thatte HS; Anderson KC; Munshi NC
Blood; 2006 Jan; 107(1):301-4. PubMed ID: 16150935
[TBL] [Abstract][Full Text] [Related]
2. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
[TBL] [Abstract][Full Text] [Related]
3. Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.
Frassanito MA; Ruggieri S; Desantis V; Di Marzo L; Leone P; Racanelli V; Fumarulo R; Dammacco F; Vacca A
Eur J Haematol; 2015 Jul; 95(1):65-74. PubMed ID: 25409753
[TBL] [Abstract][Full Text] [Related]
4. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the role of Tregs in the progression of multiple myeloma.
Lad D; Huang Q; Hoeppli R; Garcia R; Xu L; Levings M; Song K; Broady R
Leuk Lymphoma; 2019 Sep; 60(9):2134-2142. PubMed ID: 30773086
[TBL] [Abstract][Full Text] [Related]
6. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
[TBL] [Abstract][Full Text] [Related]
7. Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients.
Huang LQ; Wang JX; He K; Jiang YZ; Wei ZL; Huang DP; Chu LL
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):113-117. PubMed ID: 29729703
[TBL] [Abstract][Full Text] [Related]
8. Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.
D'Arena G; Rossi G; Laurenti L; Statuto T; D'Auria F; Valvano L; Simeon V; Giudice A; Innocenti I; De Feo V; Filosa R; Musto P
J Immunol Res; 2016; 2016():9271469. PubMed ID: 27493974
[TBL] [Abstract][Full Text] [Related]
9. Treg and Oligoclonal Expansion of Terminal Effector CD8
Joshua DE; Vuckovic S; Favaloro J; Lau KHA; Yang S; Bryant CE; Gibson J; Ho PJ
Front Immunol; 2021; 12():620596. PubMed ID: 33708212
[TBL] [Abstract][Full Text] [Related]
10. Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.
Wang JN; Cao XX; Zhao AL; Cai H; Wang X; Li J
Cancer Cell Int; 2018; 18():187. PubMed ID: 30479566
[TBL] [Abstract][Full Text] [Related]
11. Circulating Regulatory T-Cell Number Does Not Predict Prognosis of Monoclonal Gammopathies of Uncertain Significance.
Valvano L; Calice G; Statuto T; Pietrantuono G; Mansueto G; Villani O; Marano L; D'Agostino S; D'Auria F; Traficante A; Sgambato A; D'Arena G
Crit Rev Eukaryot Gene Expr; 2021; 31(5):21-26. PubMed ID: 34591386
[TBL] [Abstract][Full Text] [Related]
12. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
[TBL] [Abstract][Full Text] [Related]
13. Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma.
Brimnes MK; Vangsted AJ; Knudsen LM; Gimsing P; Gang AO; Johnsen HE; Svane IM
Scand J Immunol; 2010 Dec; 72(6):540-7. PubMed ID: 21044128
[TBL] [Abstract][Full Text] [Related]
14. Mass Cytometry Discovers Two Discrete Subsets of CD39
Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S
Front Immunol; 2019; 10():1596. PubMed ID: 31428081
[TBL] [Abstract][Full Text] [Related]
15. Characterization of γδ regulatory T cells from peripheral blood in patients with multiple myeloma.
Ma Y; Lei H; Tan J; Xuan L; Wu X; Liu Q
Biochem Biophys Res Commun; 2016 Nov; 480(4):594-601. PubMed ID: 27793666
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
Tienhaara A; Pelliniemi TT
Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
[TBL] [Abstract][Full Text] [Related]
17. FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.
Ahmadzadeh M; Felipe-Silva A; Heemskerk B; Powell DJ; Wunderlich JR; Merino MJ; Rosenberg SA
Blood; 2008 Dec; 112(13):4953-60. PubMed ID: 18820132
[TBL] [Abstract][Full Text] [Related]
18. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
Baratelli F; Lin Y; Zhu L; Yang SC; Heuzé-Vourc'h N; Zeng G; Reckamp K; Dohadwala M; Sharma S; Dubinett SM
J Immunol; 2005 Aug; 175(3):1483-90. PubMed ID: 16034085
[TBL] [Abstract][Full Text] [Related]
20. Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.
Bae J; Accardi F; Hideshima T; Tai YT; Prabhala R; Shambley A; Wen K; Rowell S; Richardson PG; Munshi NC; Anderson KC
Leukemia; 2022 Jan; 36(1):138-154. PubMed ID: 34290359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
